Cyvex Nutrition and Solanic Form Global Distribution Alliance
This alliance will streamline global operations, with Cyvex assuming all duties relating to the supplement's sales, promotion, support and further development.
Aug 5 2011 --- Premium nutritional ingredient suppliers Cyvex Nutrition and Holland-based Solanic announced today a global distribution alliance for the dietary and weight management supplement SolaThin. This alliance will streamline global operations, with Cyvex assuming all duties relating to the supplement's sales, promotion, support and further development.
SolaThin introduced to the U.S. market in March 2011 by Cyvex Nutrition is a pure potato protein extract consisting of several low molecular weight proteins, including protease inhibitor PI-2. PI-2 enables the release of cholecystokinin (CKK), a naturally occurring peptide clinically shown to produce a feeling of gastric fullness, and thereby helping reduce food consumption. Additionally, SolaThin contains no added compounds and features more than 90 percent protein, PI-2 included, to promote optimized satiety and healthful, effective weight control.
"With healthy, effective weight management becoming an increasingly global issue, this alliance affords us a wonderful opportunity to offer a unique alternative protein ingredient to the food, beverage and dietary supplement industries," said Katherine Bond, Cyvex's director of business development. "We are thrilled to be working with a company that specializes in developing potato protein offerings backed by scientific efficacy and excellent functionality."
Under this new alliance, SolaThin will be further studied in a human clinical trial involving 60 adult subjects, with three treatment arms expected to be completed by fourth quarter of 2011.
